Thomas Braxton King, President & CEO at Alexza Pharmaceuticals Inc. (ALXA), sold 12,500 shares at $9.27 ($114K) on 2007-08-09, disclosed to the SEC on 2007-08-13.
Scheduled sale ($114k) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.25 | 2,500 | $23K | 20.2% |
| 2 | $9.00 | 2,500 | $23K | 19.7% |
| 3 | $9.05 | 2,500 | $23K | 19.8% |
| 4 | $9.11 | 100 | $911 | 0.8% |
| 5 | $9.20 | 2,100 | $19K | 16.9% |
| 6 | $9.21 | 400 |
| $4K |
| 3.2% |
| 7 | $9.27 | 2,400 | $22K | 19.4% |
| Total | $9.15 avg | 12,500 | $114K | 100% |
| Filing → |
| ALXA | SELL | 2012-08-29 | $41K | — | Filing → |
| ALXA | SELL | 2012-06-08 | $22K | — | Filing → |
| ALXA | SELL | 2009-12-21 | $100K | — | Filing → |